6 Weeks Right-Amygdala TIS for Depression
NCT: NCT07059143 · ENROLLING_BY_INVITATION
Brief Summary
The current investigation employs a directed neuromodulation technique, specifically targeting the right amygdala, to ascertain its therapeutic efficacy in managing depressive episodes. The intervention's safety and efficacy will be evaluated using an assessment incorporating depressive symptomatology, cognitive abilities, and daily functions.
Frequently Asked Questions
What is 6 Weeks Right-Amygdala TIS for Depression?
6 Weeks Right-Amygdala TIS for Depression is a clinical trial registered under NCT07059143. Current status: ENROLLING_BY_INVITATION.
What is the status of NCT07059143?
The current status of NCT07059143 (6 Weeks Right-Amygdala TIS for Depression) is: ENROLLING_BY_INVITATION.
When did 6 Weeks Right-Amygdala TIS for Depression start?
6 Weeks Right-Amygdala TIS for Depression started on 2025-05-27.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.